Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TGFBI ELISA Kit (AC3825)
Cat.#: ASET-2414
Specifications
Description Human TGFBI ELISA Kit allows for the in vitro quantitative determination of human TGFBI concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.375 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.625-40 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2370 Mouse Nell1 ELISA Kit (AC3781) Quantitative inquiry ASET-1759 Human FGFR1 ELISA Kit (AC3170) Quantitative inquiry ASET-1717 Mouse DLL4 ELISA Kit (AC3128) Quantitative inquiry ASET-2399 Human PITPNC1 ELISA Kit (AC3810) Quantitative inquiry ASET-2505 Rat Luteinizing Hormone ELISA Kit (AC3916) Quantitative inquiry ASET-2125 Mouse Heme Oxygenase 1 ELISA Kit (AC3536) Quantitative inquiry ASET-2050 Human MAL ELISA Kit (AC3461) Quantitative inquiry ASET-2004 Human Synaptopodin ELISA Kit (AC3415) Quantitative inquiry ASET-1572 Human Adenosine A1 Receptor ELISA Kit (AC2983) Quantitative inquiry ASET-1841 Human LGI3 ELISA Kit (AC3252) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket